Precision Medicine
The precision medicine company will integrate its rWGS technology with Epic, giving health systems using its EHR the ability to gain genomic insights for pediatric and neonatal patients.
As a result, it can now more easily find clinical trial patients matching ultra-rare diseases or mind-boggling clinical requirements.
Researchers compare machine learning models to traditional alerts for critically ill adults, while a new real-world GLP-1 data trove incorporates unstructured data. Also, RapidAI earns another FDA clearance for rapid stroke imaging.
Universal Brain Founder and CEO Dr. Kazu Okuda, a psychiatrist, discusses precision psychiatry and the technology that facilitates this form of treatment in the home.
NVIDIA Healthcare this week announced integration with Amazon Web Services for NIM, its suite of microservices designed to empower foundational models in the realms of drug discovery, medical imaging and genomics.
People respond differently to medications. Prescribing could be optimised through pharmacogenomic testing, which could reduce medication waste, notes Clinical Innovation Lead for the University of Manchester Videha Sharma.
The centre integrates three AI systems that work in tandem to enable the early detection and diagnosis of stomach cancers.
The data and technology company is partnering with BillionToOne on diagnostic solutions in oncology.
The tools can help integrate artificial intelligence into existing applications that can be run from the cloud or on-prem – focused on genomics, imaging, drug discovery and other digital health priorities.
Also, robotic technology underpins Apollo Proton Cancer Centre's newest rectal cancer centre.
